Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL2975221

CCCC[N+](CCCC)(CCCC)CCCC.ClCCl.[O-][Cl+3]([O-])([O-])[O-]

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SLC22A1 O15245 3/20 0.63
▸ SLC22A2 O15244 1/20 0.55
▸ ALDH1A1 P00352 2/20 0.50
▸ TSHR P16473 2/20 0.50
▸ TP53 P04637 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ ALOX15 P16050 1/20 0.50
▸ ALOX12 P18054 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ HIF1A Q16665 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ DNM1 Q05193 5/20 0.46
▸ PLA2G1B P04054 1/20 0.39
▸ HSP90AA1 P07900 1/20 0.39
▸ RAD52 P43351 1/20 0.39
▸ ATG4B Q9Y4P1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL29528734 0.92 SLC22A1 (0.75) SLC22A1SLC22A2ALDH1A1TSHRTP53
Tetrabuthylammonium SCHEMBL35671 0.92 SLC22A1 (0.75) SLC22A1SLC22A2ALDH1A1TSHRTP53
Tetrabuthylammonium SCHEMBL3152950 0.89 SLC22A1 (0.71) SLC22A1SLC22A2ALDH1A1TSHRTP53
Tetrabuthylammonium SCHEMBL2781154 0.89 SLC22A1 (0.71) SLC22A1SLC22A2ALDH1A1TSHRTP53
Tetrabuthylammonium SCHEMBL2781153 0.89 SLC22A1 (0.71) SLC22A1SLC22A2ALDH1A1TSHRTP53
Perchlorate SCHEMBL11841092 0.86 SLC22A1 (0.72) SLC22A1SLC22A2ALDH1A1TSHRTP53
Tetrabuthylammonium SCHEMBL9174985 0.86 SLC22A1 (0.67) SLC22A1SLC22A2ALDH1A1TSHRTP53
Tetrapentylammonium SCHEMBL160424 0.86 SLC22A1 (0.75) SLC22A1SLC22A2ALDH1A1TSHRTP53
Tetrapentylammonium SCHEMBL30354995 0.86 SLC22A1 (0.75) SLC22A1SLC22A2ALDH1A1TSHRTP53
Tetrabuthylammonium SCHEMBL6545372 0.86 SLC22A1 (0.75) SLC22A1SLC22A2ALDH1A1TSHRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1672961-B1 COMPOUND, CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE MITSUBISHI CHEM CORP (JP) 2014-12-03 — — EP disclosed
EP-2592905-B1 Compound, charge transporting material and organic electroluminescent element MITSUBISHI CHEM CORP (JP) 2014-11-12 — — EP disclosed
EP-2592905-A1 Compound, charge transporting material and organic electroluminescent element Mitsubishi Chemical Corporation (JP) 2013-05-15 — — EP disclosed
US-7777043-B2 Compound, charge transporting material and organic electroluminescent element MITSUBISHI CHEMICAL CORPORATION (JP) 2010-08-17 — — US disclosed
US-20060186796-A1 Compound, charge transporting material and organic electroluminescent element MITSUBISHI CHEMICAL CORPORATION (JP) 2006-08-24 — — US disclosed
EP-1672961-A1 COMPOUND, CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE Mitsubishi Chemical Corporation (JP) 2006-06-21 — — EP disclosed
US-5277789-A Metal, metal alloy, and metal oxide formation by electrodeposition of polymetalllic complexes TUFTS UNIVERSITY (US) 1994-01-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060186796-A1 Compound, charge transporting material and organic electroluminescent element SLCO4C1, SLC26A3, SLC7A5 SLC22A1 38/4885SLC22A2 33/4885ALDH1A1 945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback